Effect of Ascaris Lumbricoides specific IgE on tuberculin skin test responses in children in a high-burden setting: a cross-sectional community-based study

BMC Infectious Diseases

Volumn 12, Issue , 2012, Pages

  van Soelen, Nelda ^a   Mandalakas, Anna M ^a,b,c   Kirchner, H L ^d   Walzl, Gerhard ^e   Grewal, Harleen M S ^f   Jacobsen, Marc ^g   Hesseling, Anneke C ^a  

^a UNIVERSITY OF STELLENBOSCH   (South Africa)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c TEXAS CHILDREN S HOSPITAL   (United States)

^d GEISINGER MEDICAL CENTER   (United States)

^e STELLENBOSCH UNIVERSITY   (South Africa)

^f UNIVERSITY OF BERGEN   (Norway)

^g UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

Ascaris, M.tb infection; Helminth infection; Immune polarization; Paediatric tuberculosis; Tuberculosis

Indexed keywords

BCG VACCINE; IMMUNOGLOBULIN E; ISONIAZID;

ADOLESCENT; ADULT; AGE; ANTIGEN SPECIFICITY; ARTICLE; ASCARIASIS; ASCARIS LUMBRICOIDES; CHILD; COMMUNITY ASSESSMENT; CONTACT SCORE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; FEMALE; HEALTH STATUS; HELMINTHIASIS; HOUSEHOLD; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; INFANT; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM; NONHUMAN; POPULATION RESEARCH; PRESCHOOL CHILD; SCAR; SCHOOL CHILD; SCORING SYSTEM; TH1 CELL; TUBERCULIN TEST; TUBERCULOSIS;

ADOLESCENT; ANIMALS; ANTIBODIES, HELMINTH; ASCARIASIS; ASCARIS LUMBRICOIDES; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; FEMALE; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNOGLOBULIN E; INFANT; MALE; MICROBIAL INTERACTIONS; PREVALENCE; PROSPECTIVE STUDIES; TUBERCULIN TEST; TUBERCULOSIS; URBAN POPULATION;

EID: 84865966693     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-12-211     Document Type: Article

References (43)

1. WHO Global tuberculosis control: WHO report 2010 2010, Geneva, Switzerland: World Health Organization, WHO.
2. Corbett EL, Watt CJ, Walker N, Maher D, Williams BG, Raviglione MC, Dye C. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med 2003, 163(9):1009-1021. 10.1001/archinte.163.9.1009, 12742798.
3. Marais BJ, Gie RP, Schaaf HS, Hesseling AC, Obihara CC, Starke JJ, Enarson DA, Donald PR, Beyers N. The natural history of childhood intra-thoracic tuberculosis: a critical review of literature from the pre-chemotherapy era. Int J Tuberc Lung Dis 2004, 8(4):392-402.
4. Appleton CC, Mosala TI, Levin J, Olsen A. Geohelminth infection and re-infection after chemotherapy among slum-dwelling children in Durban, South Africa. Ann Trop Med Parasitol 2009, 103(3):249-261. 10.1179/136485909X398212, 19341539.
5. Saathoff E, Olsen A, Kvalsvig JD, Appleton CC. Patterns of geohelminth infection, impact of albendazole treatment and re-infection after treatment in schoolchildren from rural KwaZulu-Natal/South-Africa. BMC Infect Dis 2004, 4:27. 10.1186/1471-2334-4-27, 514548, 15310401.
6. Albonico M, Allen H, Chitsulo L, Engels D, Gabrielli AF, Savioli L. Controlling soil-transmitted helminthiasis in pre-school-age children through preventive chemotherapy. PLoS Negl Trop Dis 2008, 2(3):e126. 10.1371/journal.pntd.0000126, 2274864, 18365031.
7. Ezeamama AE, Friedman JF, Acosta LP, Bellinger DC, Langdon GC, Manalo DL, Olveda RM, Kurtis JD, McGarvey ST. Helminth infection and cognitive impairment among Filipino children. AmJTrop Med Hyg 2005, 72(5):540-548.
8. Jardim-Botelho A, Raff S, Rodrigues Rde A, Hoffman HJ, Diemert DJ, Correa-Oliveira R, Bethony JM, Gazzinelli MF. Hookworm, Ascaris lumbricoides infection and polyparasitism associated with poor cognitive performance in Brazilian schoolchildren. Trop Med Int Health 2008, 13(8):994-1004. 10.1111/j.1365-3156.2008.02103.x, 18627581.
9. WHO Weekly epidemiological record 2010, 141-148. 85, WHO.
10. WHO Integrated Management of Childhood Illness 2008, WHO.
11. Young DB, Gideon HP, Wilkinson RJ. Eliminating latent tuberculosis. Trends Microbiol 2009, 17(5):183-188. 10.1016/j.tim.2009.02.005, 19375916.
12. Tuberculosis: A Comprehensive Clinical Reference 2009, Schaaf HS, Zumla A.
13. Lewinsohn DA, Gennaro ML, Scholvinck L, Lewinsohn DM. Tuberculosis immunology in children: diagnostic and therapeutic challenges and opportunities. Int J Tuberc Lung Dis 2004, 8(5):658-674.
14. Winek J, Demkow U, Rowinska-Zakrzewska E, Szolkowska M, Filewska M, Jagodzinski J, Roszkowski-Sliz K. Comparison of Th1 and Th2 response in the blood of tuberculous patients and healthy contacts. Pneumonol Alergol Pol 2009, 77(5):446-452.
15. Elias D, Mengistu G, Akuffo H, Britton S. Are intestinal helminths risk factors for developing active tuberculosis?. Trop Med Int Health 2006, 11(4):551-558. 10.1111/j.1365-3156.2006.01578.x, 16553939.
16. Demissie A, Abebe M, Aseffa A, Rook G, Fletcher H, Zumla A, Weldingh K, Brock I, Andersen P, Doherty TM. Healthy Individuals That Control a Latent Infection with Mycobacterium tuberculosis Express High Levels of Th1 Cytokines and the IL-4 Antagonist IL-4{delta}2. J Immunol 2004, 172(11):6938-6943.
17. Wigginton JE, Kirschner D. A model to predict cell-mediated immune regulatory mechanisms during human infection with Mycobacterium tuberculosis. J Immunol 2001, 166(3):1951-1967.
18. Yazdanbakhsh M, van den Biggelaar A, Maizels RM. Th2 responses without atopy: immunoregulation in chronic helminth infections and reduced allergic disease. Trends Immunol 2001, 22(7):372-377. 10.1016/S1471-4906(01)01958-5, 11429321.
19. Borkow G, Leng Q, Weisman Z, Stein M, Galai N, Kalinkovich A, Bentwich Z. Chronic immune activation associated with intestinal helminth infections results in impaired signal transduction and anergy. J Clin Invest 2000, 106(8):1053-1060. 10.1172/JCI10182, 314342, 11032865.
20. Cooper PJ, Chico ME, Sandoval C, Espinel I, Guevara A, Kennedy MW, Urban JF, Griffin GE, Nutman TB. Human infection with Ascaris lumbricoides is associated with a polarized cytokine response. J Infect Dis 2000, 182(4):1207-1213. 10.1086/315830, 10979919.
21. Resende Co T, Hirsch CS, Toossi Z, Dietze R, Ribeiro-Rodrigues R. Intestinal helminth co-infection has a negative impact on both anti-Mycobacterium tuberculosis immunity and clinical response to tuberculosis therapy. Clin Exp Immunol 2007, 147(1):45-52. 1810442, 17177962.
22. Wright VJ, Ame SM, Haji HS, Weir RE, Goodman D, Pritchard DI, Mohamed MR, Haji HJ, Tielsch JM, Stoltzfus RJ, et al. Early exposure of infants to GI nematodes induces Th2 dominant immune responses which are unaffected by periodic anthelminthic treatment. PLoS Negl Trop Dis 2009, 3(5):e433. 10.1371/journal.pntd.0000433, 2677666, 19436745.
23. Tristao-Sa R, Ribeiro-Rodrigues R, Johnson LT, Pereira FE, Dietze R. Intestinal nematodes and pulmonary tuberculosis. Rev Soc Bras Med Trop 2002, 35(5):533-535. 10.1590/S0037-86822002000500020, 12621678.
24. Potian JA, Rafi W, Bhatt K, McBride A, Gause WC, Salgame P. Preexisting helminth infection induces inhibition of innate pulmonary anti-tuberculosis defense by engaging the IL-4 receptor pathway. The Journal of Experimental Medicine 2011, 208(9):1863-1874. 10.1084/jem.20091473, 3171086, 21825018.
25. Neto LM, Oliveira Rde V, Totino PR, Sant'Anna FM, Coelho Vde O, Rolla VC, Zanini GM. Enteroparasitosis prevalence and parasitism influence in clinical outcomes of tuberculosis patients with or without HIV co-infection in a reference hospital in Rio de Janeiro (2000-2006). Braz J Infect Dis 2009, 13(6):427-432.
26. Adams VJ, Markus MB, Adams JF, Jordaan E, Curtis B, Dhansay MA, Obihara CC, Fincham JE. Paradoxical helminthiasis and giardiasis in Cape Town, South Africa: epidemiology and control. Afr Health Sci 2005, 5(3):276-280. 1831923, 16246001.
27. Marais BJ, Gie RP, Hesseling AC, Schaaf HS, Enarson DA, Beyers N. Radiographic signs and symptoms in children treated for tuberculosis: possible implications for symptom-based screening in resource-limited settings. Pediatr Infect Dis J 2006, 25(3):237-240. 10.1097/01.inf.0000202140.76368.74, 16511386.
28. Marais BJ, Gie RP, Hesseling AC, Schaaf HS, Lombard C, Enarson DA, Beyers N. A refined symptom-based approach to diagnose pulmonary tuberculosis in children. Pediatrics 2006, 118(5):e1350-1359. 10.1542/peds.2006-0519, 17079536.
29. Mandalakas AM, Kirchner HL, Lombard C, Walzl G, Grewal HMS, Gie RP, Hesseling AC. Well-quantified tuberculosis exposure is a reliable surrogate measure for tuberculosis infection. Int J Tuberc Lung Dis 2012, 16(7).
30. Hesseling AC, Mandalakas AM, Kirchner HL, Chegou NN, Marais BJ, Stanley K, Zhu X, Black G, Beyers N, Walzl G. Highly discordant T cell responses in individuals with recent exposure to household tuberculosis. Thorax 2009, 64(10):840-846. 10.1136/thx.2007.085340, 18682523.
31. Shams H, Weis SE, Klucar P, Lalvani A, Moonan PK, Pogoda JM, Ewer K, Barnes PF. Enzyme-linked immunospot and tuberculin skin testing to detect latent tuberculosis infection. Am J Respir Crit Care Med 2005, 172(9):1161-1168. 10.1164/rccm.200505-748OC, 2718400, 16081545.
32. Kuczmarski RJ, Ogden CL, Guo SS, et al. 2000 CDC growth charts for the United States: Methods and development. National Center for Health Statistics. Vital Health Stat 2002, 11(246).
33. ImmunoCAP Specific IgE Fluoroenzymeimmunoassay Calibration Range 0=100kU/l 2008, Uppsala, Sweden: Phadia AB.
34. Mandalakas AM, Detjen AK, Hesseling AC, Benedetti A, Menzies D. Interferon-gamma Release Assays and Childhood Tuberculosis: systematic review and meta-analysis. Int J Tuberc Lung Dis 2011, 15(8):1018-32. 10.5588/ijtld.10.0631, 21669030.
35. Lalvani A, Bakir M, Millington KA, Dosanjh D, Soysal A. BCG and protection against Mycobacterium tuberculosis infection. Lancet 2006, 367(9508):391-392.
36. Jeremiah K, Praygod G, Faurholt-Jepsen D, Range N, Andersen AB, Grewal HM, Friis H. BCG vaccination status may predict sputum conversion in patients with pulmonary tuberculosis: a new consideration for an old vaccine?. Thorax 2010, 65(12):1072-1076. 10.1136/thx.2010.134767, 20889521.
37. Soysal A, Millington KA, Bakir M, Dosanjh D, Aslan Y, Deeks JJ, Efe S, Staveley I, Ewer K, Lalvani A. Effect of BCG vaccination on risk of Mycobacterium tuberculosis infection in children with household tuberculosis contact: a prospective community-based study. Lancet 2005, 366(9495):1443-1451. 10.1016/S0140-6736(05)67534-4, 16243089.
38. Mahomed H, Hawkridge T, Verver S, Geiter L, Hatherill M, Abrahams DA, Ehrlich R, Hanekom WA, Hussey GD. SATVI Adolescent Study Team: Predictive factors for latent tuberculosis infection among adolescents in a high-burden area in South Africa. Int J Tuberc Lung Dis 2011, 15:331-336.
39. Haswell-Elkins MR, Leonard H, Kennedy MW, Elkins DB, Maizels RM. Immunoepidemiology of Ascaris lumbricoides: relationships between antibody specificities, exposure and infection in a human community. Parasitology 1992, 104(Pt 1):153-159.
40. Figueiredo CA, Barreto ML, Rodrigues LC, Cooper PJ, Silva NB, Amorim LD, Alcantara-Neves NM. Chronic Intestinal Helminth Infections Are Associated with Immune Hyporesponsiveness and Induction of a Regulatory Network. Infect Immun 2010, 78(no 7):3160-3167. 10.1128/IAI.01228-09, 2897394, 20404082.
41. van Zyl S, Marais BJ, Hesseling AC, Gie RP, Beyers N, Schaaf HS. Adherence to anti-tuberculosis chemoprophylaxis and treatment in children. Int J Tuberc Lung Dis 2006, 10(1):13-18.
42. Marais BJ, van Zyl S, Schaaf HS, van Aardt M, Gie RP, Beyers N. Adherence to isoniazid preventive chemotherapy: a prospective community based study. Arch Dis Child 2006, 91(9):762-765. 10.1136/adc.2006.097220, 2082929, 16737993.
43. Van Wyk SS, Hamade H, Hesseling AC, Beyers N, Enarson DA, Mandalakas AM. Recording isoniazid preventive therapy delivery to children: operational challenges. Int J Tuberc Lung Dis 2010, 14(5):650-653.